Author Archives: vekstrom90

This week I will be featuring the Multidisciplinary Association for Psychedelic Studies (MAPS) organization that was founded by Rick Doblin in 1986. I have mentioned this organization several times throughout prior blog posts, but this one will go into greater depth about the organization and the founder. Healthcare financing and strategies for sustaining innovation willContinue reading “Financing & Sustaining Innovation”

This week I will discuss the impacts of technology innovations and implications for data and privacy related to psychedelic-assisted psychotherapy. At this time, I am unaware of any technology innovations that directly linked, but many existing technologies are used and support the topic. A few that come to mind are electroencephalography (EEG), magnetic resonance imagingContinue reading “Technology & Entheogens”

I have discussed several private sector institutions regarding this topic in previous posts and in the health policy brief. But for review, the major private innovators in the United States (US) regarding the use of psychedelics are the Multidisciplinary Association for Psychedelic Studies (MAPS) and John Hopkins Center for Psychedelic Consciousness and Research (CPCR). BecauseContinue reading “Private Sector: Innovation in the United States and around the Globe”

Most of the focus for the blog has been on the government institutions involved. This post will focus on the influence of public sector institutions on psychedelic-assisted psychotherapy and hallucinogen research. One major institution that I have previously mentioned is the Multidisciplinary Association for Psychedelic Studies (MAPS), a non-profit research and educational organization advocating theContinue reading “Influence of the public sector”

In my first post, I discussed the Controlled Substances Act and the Comprehensive Drug Abuse Prevention and Control Act of 1970 (current statutory and regulatory mechanisms), and the process for changing the schedule of a drug. Listed below are the current government institutions relevant to the discussion of hallucinogen research. The executive branch of theContinue reading “Major players: past and present”

Healthcare policy impacts many areas because health is a function of numerous intersecting variables, commonly referred to as health determinants (Longest, 2009). These variables include human biology and behavior, social and physical environments, policies and interventions, and quality health services ( Healthy People, 2019). Health policies are established at federal, state, and local levels andContinue reading “Ethical considerations & Hallucinogens”

History, relevance, and current position The word psychedelic can be defined as a mental state characterized by a profound sense of intensified sensory perception, sometimes accompanied by severe perceptual distortion and hallucinations and by extreme feelings of either euphoria or despair (Psychedelic, 2020). Psychedelic substances have been referred to as entheogens. An entheogen is aContinue reading “The Story: A trip down memory lane”